Healthcare provider profile · identity verified

Jonathan Gendel, MD

Internal Medicine · OVERLAND PARK, KS · NPI 1639160633

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1036	303
Levothyroxine Sodium	Levothyroxine Sodium	686	181
Amlodipine Besylate	Amlodipine Besylate	573	166
Lisinopril	Lisinopril	416	116
Losartan Potassium	Losartan Potassium	346	98
Pantoprazole Sodium	Pantoprazole Sodium	306	97
Rosuvastatin Calcium	Rosuvastatin Calcium	255	81
Simvastatin	Simvastatin	233	64
Metformin Hcl	Metformin Hcl	216	58
Omeprazole	Omeprazole	212	66
Metoprolol Succinate	Metoprolol Succinate	201	62
Carvedilol	Carvedilol	188	47
Hydrochlorothiazide	Hydrochlorothiazide	188	52
Metformin Hcl Er	Metformin Hcl	180	54
Eliquis	Apixaban	163	40
Trazodone Hcl	Trazodone Hcl	163	49
Escitalopram Oxalate	Escitalopram Oxalate	150	46
Gabapentin	Gabapentin	150	53
Allopurinol	Allopurinol	149	43
Tamsulosin Hcl	Tamsulosin Hcl	147	46
Alendronate Sodium	Alendronate Sodium	138	50
Alprazolam	Alprazolam	120	36
Sertraline Hcl	Sertraline Hcl	120	34
Potassium Chloride	Potassium Chloride	108	31
Ezetimibe	Ezetimibe	107	31
Albuterol Sulfate Hfa	Albuterol Sulfate	105	37
Meloxicam	Meloxicam	105	24
Montelukast Sodium	Montelukast Sodium	96	27
Duloxetine Hcl	Duloxetine Hcl	87	27
Clopidogrel	Clopidogrel Bisulfate	85	19
Pravastatin Sodium	Pravastatin Sodium	84	30
Citalopram Hbr	Citalopram Hydrobromide	83	21
Jardiance	Empagliflozin	83	20
Metoprolol Tartrate	Metoprolol Tartrate	81	24
Ozempic	Semaglutide	74	17
Zolpidem Tartrate	Zolpidem Tartrate	67	26
Tramadol Hcl	Tramadol Hcl	63	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	18
Glimepiride	Glimepiride	58	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	15
Finasteride	Finasteride	57	15
Venlafaxine Hcl Er	Venlafaxine Hcl	57	11
Furosemide	Furosemide	56	24
Synthroid	Levothyroxine Sodium	53	15
Famotidine	Famotidine	52	19
Fluticasone Propionate	Fluticasone Propionate	50	17
Bupropion Xl	Bupropion Hcl	49	18
Mirtazapine	Mirtazapine	48	14
Ipratropium Bromide	Ipratropium Bromide	47	14
Atenolol	Atenolol	45	12
Lovastatin	Lovastatin	45	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	42	14
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	12
Testosterone Cypionate	Testosterone Cypionate	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	11
Buspirone Hcl	Buspirone Hcl	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	12
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Irbesartan	Irbesartan	36	12
Xarelto	Rivaroxaban	36	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	34	34
Baclofen	Baclofen	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Morphine Sulfate Er	Morphine Sulfate	32	suppressed
Glipizide	Glipizide	31	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Valsartan	Valsartan	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Myrbetriq	Mirabegron	29	11
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Lorazepam	Lorazepam	28	suppressed
Terazosin Hcl	Terazosin Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	12
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Ramipril	Ramipril	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Trulicity	Dulaglutide	23	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Cephalexin	Cephalexin	20	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Sucralfate	Sucralfate	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Indapamide	Indapamide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Chlorthalidone	Chlorthalidone	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Linzess	Linaclotide	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Risperdal	Risperidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Topiramate	Topiramate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Azithromycin	Azithromycin	11	11
Brilinta	Ticagrelor	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Felodipine Er	Felodipine	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error